Medpedia

News & Analysis » Diseases and Conditions » The Tangled Neuron

From The Financial Industry, A Gloomy View of Alzheimer's Research

By Mona Johnson
Sep 02, 10 09:45AM | 0 comments
There’s been a lot of optimistic headlines about diagnosing, treating and curing Alzheimer’s lately. It seems some financial and industry analysts are not so optimistic. MarketWatch reports that the September issue of Neuroinvestment contains an extremely gloomy assessment of prospects...
Click here to read the full post

Comments

To add a comment to the original post, click here.

You must be signed in to post a comment.

Sign in now

There are no comments for this post.

Contributor

604140816_square
By Mona Johnson
From The Tangled Neuron

More from this contributor

»» See all Posts

Browse News & Analysis by Channel

Browse News & Analysis by Keywords

Diabetes Mellitus Emergency Medicine Dementia Health Policy & Management Technology Health Pain Obesity Medicine Research Public Health Nutrition Psychiatry Global Health Aging and End of Life Healthcare Breast Neoplasms Health Care Reform Health 2.0 Women's Health Medical education Medical Students Attention Deficit Disorder with Hyperactivity Caregiving Alzheimer Disease
» See all
Medpedia Portals - Adult Primary Care Allergy and Immunology Anatomy Cardiology Emergency Medicine Endocrinology Epidemiology Gastroenterology and Hepatology General Medicine Infectious Diseases Internal Medicine Neurology & Neurobiology Nutrition OB/GYN and Reproductive Health Oncology Orthopedics Pathology Pediatrics Pharmacology Psychiatry Public Health Pulmonology Rheumatology Women's Health
Editor Directory - browse by last initial
ABCDEFGHIJKLMNOPQRSTUVWXYZ
Professional Directory - browse by last initial
ABCDEFGHIJKLMNOPQRSTUVWXYZ
About Medpedia | Privacy Policy | Terms of Use | Contact | Press | FAQ | Medical School Network
Content on this page is the sole copyright of the author.
Cancel
Cancel